Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
14151 | 723 | 37.2 | 58% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MALE CONTRACEPTION | Author keyword | 48 | 47% | 10% | 74 |
2 | VAS OCCLUSION | Author keyword | 21 | 85% | 2% | 11 |
3 | MALE HORMONAL CONTRACEPTION | Author keyword | 20 | 100% | 1% | 9 |
4 | REPROD CONTRACEPT | Address | 17 | 63% | 2% | 17 |
5 | RISUG | Author keyword | 15 | 88% | 1% | 7 |
6 | REPROD ENDOCRINOL TOXICOL | Address | 13 | 80% | 1% | 8 |
7 | MALE CONTRACEPTIVE AGENTS | Author keyword | 12 | 86% | 1% | 6 |
8 | POPULAT REPROD | Address | 8 | 41% | 2% | 16 |
9 | MALE CONTRACEPTIVE | Author keyword | 8 | 46% | 2% | 13 |
10 | 7 ALPHA METHYL 19 NORTESTOSTERONE | Author keyword | 8 | 100% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MALE CONTRACEPTION | 48 | 47% | 10% | 74 | Search MALE+CONTRACEPTION | Search MALE+CONTRACEPTION |
2 | VAS OCCLUSION | 21 | 85% | 2% | 11 | Search VAS+OCCLUSION | Search VAS+OCCLUSION |
3 | MALE HORMONAL CONTRACEPTION | 20 | 100% | 1% | 9 | Search MALE+HORMONAL+CONTRACEPTION | Search MALE+HORMONAL+CONTRACEPTION |
4 | RISUG | 15 | 88% | 1% | 7 | Search RISUG | Search RISUG |
5 | MALE CONTRACEPTIVE AGENTS | 12 | 86% | 1% | 6 | Search MALE+CONTRACEPTIVE+AGENTS | Search MALE+CONTRACEPTIVE+AGENTS |
6 | MALE CONTRACEPTIVE | 8 | 46% | 2% | 13 | Search MALE+CONTRACEPTIVE | Search MALE+CONTRACEPTIVE |
7 | 7 ALPHA METHYL 19 NORTESTOSTERONE | 8 | 100% | 1% | 5 | Search 7+ALPHA+METHYL+19+NORTESTOSTERONE | Search 7+ALPHA+METHYL+19+NORTESTOSTERONE |
8 | SPERM SUPPRESSION | 8 | 100% | 1% | 5 | Search SPERM+SUPPRESSION | Search SPERM+SUPPRESSION |
9 | TESTOSTERONE BUCICLATE | 6 | 80% | 1% | 4 | Search TESTOSTERONE+BUCICLATE | Search TESTOSTERONE+BUCICLATE |
10 | SPERMATOGENIC SUPPRESSION | 6 | 100% | 1% | 4 | Search SPERMATOGENIC+SUPPRESSION | Search SPERMATOGENIC+SUPPRESSION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EFFECTIVELY SUPPRESSES SPERMATOGENESIS | 80 | 100% | 3% | 25 |
2 | ENANTHATE INDUCED AZOOSPERMIA | 54 | 80% | 5% | 33 |
3 | INJECTABLE TESTOSTERONE UNDECANOATE | 48 | 91% | 3% | 20 |
4 | INDUCED AZOOSPERMIA | 34 | 69% | 4% | 29 |
5 | MALE CONTRACEPTION | 31 | 47% | 7% | 50 |
6 | TESTOSTERONE ENANTHATE | 28 | 58% | 4% | 32 |
7 | ENANTHATE | 28 | 53% | 5% | 37 |
8 | NORETHISTERONE ENANTHATE | 28 | 69% | 3% | 24 |
9 | MONTHLY INJECTIONS | 27 | 92% | 2% | 11 |
10 | ORAL DESOGESTREL | 27 | 92% | 2% | 11 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
7 alpha-Methyl-19-nortestosterone (MENTR): the Population Council's contribution to research on male contraception and treatment of hypogonadism | 2013 | 6 | 34 | 85% |
Clinical trials in male hormonal contraception | 2010 | 17 | 64 | 97% |
Identification of specific sites of hormonal regulation in spermatogenesis in rats, monkeys, and man | 2002 | 170 | 80 | 49% |
Progress towards hormonal male contraception | 2004 | 49 | 46 | 91% |
Drug Insight: recent advances in male hormonal contraception | 2006 | 31 | 64 | 84% |
Acceptability of contraception for men: a review | 2010 | 9 | 10 | 80% |
Advances in male contraception | 2008 | 50 | 346 | 33% |
Steroid hormones for contraception in men | 2007 | 8 | 53 | 94% |
Hormonal regulation of male germ cell development | 2010 | 50 | 129 | 22% |
Male hormonal contraception: Where do we stand? | 2012 | 2 | 32 | 75% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | REPROD CONTRACEPT | 17 | 63% | 2.4% | 17 |
2 | REPROD ENDOCRINOL TOXICOL | 13 | 80% | 1.1% | 8 |
3 | POPULAT REPROD | 8 | 41% | 2.2% | 16 |
4 | CONTRACEPT DEV NETWORK | 5 | 38% | 1.4% | 10 |
5 | REPROD MED STEINFURTER STR 107 | 4 | 75% | 0.4% | 3 |
6 | MED POPULAT REPROD | 2 | 38% | 0.7% | 5 |
7 | MALE CLIN | 2 | 44% | 0.6% | 4 |
8 | STEINFURTER STR 107 | 2 | 67% | 0.3% | 2 |
9 | REPROD PHYSIOL SECT | 1 | 14% | 1.2% | 9 |
10 | JIANGSU FAMILY PLANNING | 1 | 100% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000179385 | 5 HEXANEDIONE//AVEN//SPATA4 |
2 | 0.0000167530 | AZALINE B//ANTIOVULATORY ACTIVITY//LHRH ANTAGONISTS |
3 | 0.0000140172 | FSH THERAPY//FSH TREATMENT//IDIOPATHIC OLIGOASTHENOTERATOZOOSPERMIA |
4 | 0.0000134605 | P450 ENZYME//ENZYMELESS BIOSENSORS//IRON TETRAPYRIDINOPORPHYRAZINE |
5 | 0.0000122444 | EFFERENT DUCTULES//BIOCHIM IRBA//UP EA 2608 |
6 | 0.0000119017 | MARY M WOHLFORD MALE CONTRACEPT//ECTOPLASMIC SPECIALIZATION//BLOOD TESTIS BARRIER |
7 | 0.0000117643 | DURATION OF SPERMATOGENESIS//SPERMATOGENIC CYCLE LENGTH//SPERMATOGENIC EFFICIENCY |
8 | 0.0000101466 | HYPOGONADISM//LATE ONSET HYPOGONADISM//TESTOSTERONE REPLACEMENT THERAPY |
9 | 0.0000095132 | VASOVASOSTOMY//VASECTOMY//VASECTOMY REVERSAL |
10 | 0.0000081487 | FSH RECEPTOR//FOLLICLE STIMULATING HORMONE RECEPTOR//LUTEINIZING HORMONE RECEPTOR |